1. Home
  2. AXSM vs GBTG Comparison

AXSM vs GBTG Comparison

Compare AXSM & GBTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXSM
  • GBTG
  • Stock Information
  • Founded
  • AXSM 2012
  • GBTG 2014
  • Country
  • AXSM United States
  • GBTG United States
  • Employees
  • AXSM N/A
  • GBTG N/A
  • Industry
  • AXSM Biotechnology: Pharmaceutical Preparations
  • GBTG Computer Software: Prepackaged Software
  • Sector
  • AXSM Health Care
  • GBTG Technology
  • Exchange
  • AXSM Nasdaq
  • GBTG Nasdaq
  • Market Cap
  • AXSM 4.7B
  • GBTG 4.3B
  • IPO Year
  • AXSM 2015
  • GBTG N/A
  • Fundamental
  • Price
  • AXSM $90.73
  • GBTG $9.34
  • Analyst Decision
  • AXSM Strong Buy
  • GBTG Strong Buy
  • Analyst Count
  • AXSM 14
  • GBTG 4
  • Target Price
  • AXSM $125.93
  • GBTG $9.88
  • AVG Volume (30 Days)
  • AXSM 499.7K
  • GBTG 1.1M
  • Earning Date
  • AXSM 02-18-2025
  • GBTG 11-05-2024
  • Dividend Yield
  • AXSM N/A
  • GBTG N/A
  • EPS Growth
  • AXSM N/A
  • GBTG N/A
  • EPS
  • AXSM N/A
  • GBTG N/A
  • Revenue
  • AXSM $338,457,000.00
  • GBTG $2,381,000,000.00
  • Revenue This Year
  • AXSM $44.89
  • GBTG $7.77
  • Revenue Next Year
  • AXSM $68.41
  • GBTG $6.24
  • P/E Ratio
  • AXSM N/A
  • GBTG N/A
  • Revenue Growth
  • AXSM 51.47
  • GBTG 4.98
  • 52 Week Low
  • AXSM $64.11
  • GBTG $4.49
  • 52 Week High
  • AXSM $105.00
  • GBTG $9.60
  • Technical
  • Relative Strength Index (RSI)
  • AXSM 42.16
  • GBTG 57.32
  • Support Level
  • AXSM $89.09
  • GBTG $8.92
  • Resistance Level
  • AXSM $94.64
  • GBTG $9.54
  • Average True Range (ATR)
  • AXSM 3.64
  • GBTG 0.19
  • MACD
  • AXSM -1.14
  • GBTG -0.06
  • Stochastic Oscillator
  • AXSM 20.64
  • GBTG 50.75

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

About GBTG Global Business Travel Group Inc.

Global Business Travel Group Inc operates as a business-to-business travel platform. It is engaged in providing software and services to manage travel, expenses, and meetings and events for companies of all sizes. The company is engaged in building the marketplace in B2B travel to deliver unrivaled choice, value, and experiences. It also provides business travel solutions, simplified travel management, and business consulting services. Further, The company generates revenue in two ways that involves fees and other revenues relating to processing and servicing travel transactions received from clients and travel suppliers and revenues for the provision of products and professional services not directly related to transactions received from clients, travel suppliers and Network Partners.

Share on Social Networks: